Literature DB >> 15057296

Acute HIV revisited: new opportunities for treatment and prevention.

Christopher D Pilcher1, Joseph J Eron, Shannon Galvin, Cynthia Gay, Myron S Cohen.   

Abstract

Inability to recognize incident infection has traditionally limited both scientific and public health approaches to HIV disease. Recently, some laboratories have begun adding HIV nucleic acid amplification testing to HIV diagnostic testing algorithms so that acute (antibody-negative) HIV infections can be routinely detected within the first 1-3 weeks of exposure. In this review article, we will highlight critical opportunities for HIV treatment and prevention that are presented by these diagnostic strategies.

Entities:  

Mesh：

Year:  2004        PMID： 15057296      PMCID： PMC379335          DOI： 10.1172/JCI21540

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


  92 in total

1.  Acute HIV infection among patients tested for mononucleosis.

Authors:  E S Rosenberg; A M Caliendo; B D Walker
Journal:  N Engl J Med       Date:  1999-03-25       Impact factor: 91.245

Review 2.  The role of the oral environment in HIV-1 transmission.

Authors:  D C Shugars; S M Wahl
Journal:  J Am Dent Assoc       Date:  1998-07       Impact factor: 3.634

Review 3.  Acute human immunodeficiency virus type 1 infection.

Authors:  J O Kahn; B D Walker
Journal:  N Engl J Med       Date:  1998-07-02       Impact factor: 91.245

4.  Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.

Authors:  J E Schmitz; M J Kuroda; S Santra; V G Sasseville; M A Simon; M A Lifton; P Racz; K Tenner-Racz; M Dalesandro; B J Scallon; J Ghrayeb; M A Forman; D C Montefiori; E P Rieber; N L Letvin; K A Reimann
Journal:  Science       Date:  1999-02-05       Impact factor: 47.728

5.  Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract.

Authors:  C E Hart; J L Lennox; M Pratt-Palmore; T C Wright; R F Schinazi; T Evans-Strickfaden; T J Bush; C Schnell; L J Conley; K A Clancy; T V Ellerbrock
Journal:  J Infect Dis       Date:  1999-04       Impact factor: 5.226

6.  Detection of human immunodeficiency virus type 1 (HIV-1) RNA in pools of sera negative for antibodies to HIV-1 and HIV-2.

Authors:  P A Morandi; G A Schockmel; S Yerly; P Burgisser; P Erb; L Matter; R Sitavanc; L Perrin
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

7.  Characteristics of primary infection of a European human immunodeficiency virus type 1 clade B isolate in chimpanzees.

Authors:  W M Bogers; W H Koornstra; R H Dubbes; P J ten Haaft; B E Verstrepen; S S Jhagjhoorsingh; A G Haaksma; H Niphuis; J D Laman; S Norley; H Schuitemaker; J Goudsmit; G Hunsmann; J L Heeney; H Wigzell
Journal:  J Gen Virol       Date:  1998-12       Impact factor: 3.891

8.  Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV.

Authors:  T E Taha; D R Hoover; G A Dallabetta; N I Kumwenda; L A Mtimavalye; L P Yang; G N Liomba; R L Broadhead; J D Chiphangwi; P G Miotti
Journal:  AIDS       Date:  1998-09-10       Impact factor: 4.177

9.  Heterosexual transmission of human immunodeficiency virus: variability of infectivity throughout the course of infection. European Study Group on Heterosexual Transmission of HIV.

Authors:  B Leynaert; A M Downs; I de Vincenzi
Journal:  Am J Epidemiol       Date:  1998-07-01       Impact factor: 4.897

10.  New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes.

Authors:  R S Janssen; G A Satten; S L Stramer; B D Rawal; T R O'Brien; B J Weiblen; F M Hecht; N Jack; F R Cleghorn; J O Kahn; M A Chesney; M P Busch
Journal:  JAMA       Date:  1998-07-01       Impact factor: 56.272
View more
  62 in total

1.  Emerging infectious diseases.

Authors:  Vincent R Racaniello
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

2.  PCR-based pooling of dried blood spots for detection of malaria parasites: optimization and application to a cohort of Ugandan children.

Authors:  Michelle S Hsiang; Michael Lin; Christian Dokomajilar; Jordan Kemere; Christopher D Pilcher; Grant Dorsey; Bryan Greenhouse
Journal:  J Clin Microbiol       Date:  2010-08-04       Impact factor: 5.948

3.  Naïve T cells are maintained in the periphery during the first 3 months of acute HIV-1 infection: implications for analysis of thymus function.

Authors:  Gregory D Sempowski; Charles B Hicks; Joseph J Eron; John A Bartlett; Laura P Hale; Guido Ferrari; Lloyd J Edwards; Susan Fiscus; Barton F Haynes
Journal:  J Clin Immunol       Date:  2005-09       Impact factor: 8.317

Review 4.  When to start antiretroviral therapy.

Authors:  Cunlin Wang; Saba W Masho; Daniel E Nixon
Journal:  Curr HIV/AIDS Rep       Date:  2006-07       Impact factor: 5.071

5.  Pooling strategies to reduce the cost of HIV-1 RNA load monitoring in a resource-limited setting.

Authors:  G U van Zyl; W Preiser; S Potschka; A T Lundershausen; R Haubrich; D Smith
Journal:  Clin Infect Dis       Date:  2011-01-15       Impact factor: 9.079

6.  Resting-state neural signatures of depressive symptoms in acute HIV.

Authors:  Carissa L Philippi; Leah Reyna; Laura Nedderman; Phillip Chan; Vishal Samboju; Kevin Chang; Nittaya Phanuphak; Nisakorn Ratnaratorn; Joanna Hellmuth; Khunthalee Benjapornpong; Netsiri Dumrongpisutikul; Mantana Pothisri; Merlin L Robb; Jintanat Ananworanich; Serena Spudich; Victor Valcour; Robert Paul
Journal:  J Neurovirol       Date:  2020-01-27       Impact factor: 2.643

7.  HPTN 062: a feasibility and acceptability pilot intervention to reduce HIV transmission risk behaviors among individuals with acute and early HIV infection in Lilongwe, Malawi.

Authors:  Amy Corneli; Audrey Pettifor; Gift Kamanga; Carol Golin; Kevin McKenna; San-San Ou; Gloria Hamela; Cecelia Massa; Francis Martinson; Jenae Tharaldson; Deborah Hilgenberg; Xuesong Yu; Wairimu Chege; Irving Hoffman
Journal:  AIDS Behav       Date:  2014-09

8.  Treatment response in acute/early infection versus advanced AIDS: equivalent first and second phases of HIV RNA decline.

Authors:  J Michael Kilby; Ha Youn Lee; J Darren Hazelwood; Anju Bansal; R Patterson Bucy; Michael S Saag; George M Shaw; Edward P Acosta; Victoria A Johnson; Alan S Perelson; Paul A Goepfert
Journal:  AIDS       Date:  2008-05-11       Impact factor: 4.177

Review 9.  The potential role of biomarkers in HIV preventive vaccine trials.

Authors:  Ellen Maclachlan; Kenneth H Mayer; Ruanne Barnabas; Jorge Sanchez; Beryl Koblin; Ann Duerr
Journal:  J Acquir Immune Defic Syndr       Date:  2009-08-15       Impact factor: 3.731

Review 10.  Rectal microbicide development.

Authors:  Ian McGowan; Charlene Dezzutti
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.